1-((8R)-7-(4-FLUOROBENZOYL)-5,6,7,8-TETRAHYDRO-8-METHYL-3-(3-METHYL-1,2,4-THIADIAZOL-5-YL)IMIDAZO(1,5-A)PYRAZIN-1-YL)-2-PYRROLIDINONE
UNII MR4G5PL5BS
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-((8r)-7-(4-fluorobenzoyl)-5,6,7,8-tetrahydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)imidazo(1,5-a)pyrazin-1-yl)-2-pyrrolidinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MR4G5PL5BS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2854332-29-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H21FN6O2S GCUMTJLKCILVPP-GFCCVEGCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-((8r)-7-(4-fluorobenzoyl)-5,6,7,8-tetrahydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)imidazo(1,5-a)pyrazin-1-yl)-2-pyrrolidinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.